文献速递乳腺乳腺X线

MyPeBS国际随机研究中乳腺影像阅片者在基于PERFORMS测试集的评估方案中的表现

Breast imaging readers' performance in the PERFORMS test-set based assessment scheme within the MyPeBS international randomised study.
PubMed 文献 · Eur J Radiol · 2025-01-19

该回顾性多国研究纳入MyPeBS临床试验中来自6个国家的110名乳腺影像阅片者,于2021年3月至2022年2月使用PERFORMS软件阅读40例富有挑战性的乳腺筛查病例测试集,计算癌症检出率与正确召回筛查率;结果显示癌症检出率均值73.6%(SD 19.7%,范围0.0%-100.0%),正确召回筛查率均值79.7%(SD 10.5%,范围46.4%-100.0%),并识别出癌症检出率极低(2.7%参与者)和正确召回筛查率极低(1.8%参与者)的离群阅片者;结论认为基于测试集的评估可反映真实世界筛查能力,离群阅片者的存在凸显双读和标准化QA方案的必要性。

要点

  • 癌症检出率均值73.6%(SD 19.7%,范围0.0%-100.0%),正确召回筛查率均值79.7%(SD 10.5%,范围46.4%-100.0%)。
  • 2.7%的参与者癌症检出率极低,1.8%的参与者正确召回筛查率极低,被识别为离群阅片者。
  • 作者认为测试集评估可反映真实世界筛查能力,离群阅片者的存在凸显双读和标准化QA协议的必要性。

核心结论

  • 乳腺影像阅片者在PERFORMS等测试集评估中的表现可反映真实世界筛查能力,离群低诊断表现阅片者的存在凸显双读和标准化QA方案对患者安全与服务效率的必要性。

研究设计与样本

  • 回顾性多国研究,110名来自6个国家的MyPeBS临床试验乳腺影像阅片者于2021年3月至2022年2月使用PERFORMS软件阅读40例富有挑战性的乳腺筛查病例测试集,其中88名还完成了关于乳腺筛查工作与经验的问卷。

诊断标准与关键数值

  • 癌症检出率均值73.6%(SD 19.7%,范围0.0%-100.0%)。
  • 正确召回筛查率均值79.7%(SD 10.5%,范围46.4%-100.0%)。
  • 癌症检出率极低的离群参与者占2.7%,正确召回筛查率极低的离群参与者占1.8%。

临床应用与阅片要点

  • 作者认为基于测试集的评估如PERFORMS可反映真实世界筛查能力。
  • 作者认为离群低诊断表现阅片者的存在凸显双读和标准化QA协议的必要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: A survey conducted by the European Society of Breast Imaging (EUSOBI) in 2023 revealed significant variations in Quality Assurance (QA) practices across Europe. The UK encourages regular performance monitoring for screen readers. This study aimed to assess the variability in diagnostic performance among readers participating in a wider prospective randomised trial across multiple countries.

METHOD: In this retrospective multinational study, breast imaging readers from the MyPeBS clinical trial examined a test set of 40 challenging breast screening cases using the PERFORMS software, from March 2021 to February 2022. The challenging set, enriched with biopsy-proven cancers, aimed to differentiate readers by their level of diagnostic performance. Cancer detection and correct return to screen rates were calculated for each participant.

RESULTS: A total of 110 readers from 6 countries completed the PERFORMS test set, while 88 also completed an accompanying questionnaire collecting information about their breast screening work and experience. The study revealed variability in cancer detection rates (M = 73.6 %, SD = 19.7 %, range 0.0 %-100.0 %) and correct return to screen rates (M = 79.7 %, SD = 10.5 %, range 46.4 %-100.0 %). Outliers with extremely low cancer detection (2.7 % of participants) and correct return to screen rates (1.8 % of participants) were also identified.

CONCLUSIONS: Breast imaging readers' performance in test set-based assessments like PERFORMS can reflect real-world screening proficiency. The presence of outlier readers with low diagnostic performance on the test highlights the need for double reading and for standardised QA protocols to ensure patient safety and service efficiency.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Michalopoulou E, Darker I, Iotti V, et al. Breast imaging readers' performance in the PERFORMS test-set based assessment scheme within the MyPeBS international randomised study. Eur J Radiol. 2025. PMID: 39855146. doi:10.1016/j.ejrad.2025.111938

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。